Redmile Group, LLC Celldex Therapeutics, Inc. Transaction History

Redmile Group, LLC

  • $822 Million
  • Q2 2025

A detailed history of Redmile Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 343,026 shares of CLDX stock, worth $9.49 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
343,026
Previous 590,175 41.88%
Holding current value
$9.49 Million
Previous $10.7 Million 34.83%
% of portfolio
0.85%
Previous 1.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$15.13 - $21.65 $3.74 Million - $5.35 Million
-247,149 Reduced 41.88%
343,026 $6.98 Million
Q1 2025

May 15, 2025
SELL
$18.15 - $27.6 $464,639 - $706,560
-25,600 Reduced 4.16%
590,175 $10.7 Million
Q4 2024

Feb 14, 2025
SELL
$23.31 - $32.4 $965,034 - $1.34 Million
-41,400 Reduced 6.3%
615,775 $15.6 Million
Q3 2024

Nov 14, 2024
SELL
$32.06 - $44.56 $1.97 Million - $2.74 Million
-61,548 Reduced 8.56%
657,175 $22.3 Million
Q2 2024

Aug 14, 2024
SELL
$32.76 - $42.56 $5.82 Million - $7.56 Million
-177,731 Reduced 19.83%
718,723 $26.6 Million
Q1 2024

May 15, 2024
SELL
$35.22 - $51.88 $3.43 Million - $5.05 Million
-97,349 Reduced 9.8%
896,454 $37.6 Million
Q4 2023

Feb 14, 2024
SELL
$22.61 - $40.65 $15.9 Million - $28.5 Million
-702,201 Reduced 41.4%
993,803 $39.4 Million
Q2 2023

Aug 14, 2023
SELL
$30.29 - $38.28 $5.57 Million - $7.03 Million
-183,735 Reduced 9.77%
1,696,004 $57.5 Million
Q1 2023

May 15, 2023
SELL
$34.78 - $47.43 $3.4 Million - $4.63 Million
-97,712 Reduced 4.94%
1,879,739 $67.6 Million
Q4 2022

Feb 14, 2023
SELL
$27.78 - $45.38 $213,906 - $349,426
-7,700 Reduced 0.39%
1,977,451 $88.1 Million
Q3 2022

Nov 14, 2022
SELL
$22.7 - $37.57 $1.93 Million - $3.2 Million
-85,137 Reduced 4.11%
1,985,151 $55.8 Million
Q2 2022

Aug 15, 2022
BUY
$20.5 - $37.33 $492,389 - $896,629
24,019 Added 1.17%
2,070,288 $55.8 Million
Q1 2022

May 16, 2022
SELL
$27.64 - $39.32 $3.3 Million - $4.69 Million
-119,317 Reduced 5.51%
2,046,269 $69.7 Million
Q4 2021

Feb 14, 2022
SELL
$35.68 - $56.27 $31.3 Million - $49.4 Million
-877,712 Reduced 28.84%
2,165,586 $83.7 Million
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $903,732 - $1.75 Million
31,217 Added 1.04%
3,043,298 $164 Million
Q2 2021

Aug 16, 2021
SELL
$20.71 - $35.37 $7.78 Million - $13.3 Million
-375,707 Reduced 11.09%
3,012,081 $101 Million
Q1 2021

May 17, 2021
BUY
$16.19 - $29.91 $10.9 Million - $20.2 Million
676,172 Added 24.94%
3,387,788 $69.8 Million
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $10.8 Million - $16.4 Million
722,416 Added 36.32%
2,711,616 $47.5 Million
Q3 2020

Nov 16, 2020
SELL
$9.65 - $15.19 $104,220 - $164,052
-10,800 Reduced 0.54%
1,989,200 $29.5 Million
Q2 2020

Aug 14, 2020
BUY
$1.61 - $13.41 $3.22 Million - $26.8 Million
2,000,000 New
2,000,000 $26 Million

Others Institutions Holding CLDX

# of Institutions
201
Shares Held
68.3M
Call Options Held
219K
Put Options Held
238K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.29B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email